3 hasil untuk "Timothy Schieber"
Menampilkan 1–3 · 0,41 detik · RSS
-
Artikel Jurnal
Complete Response to Pembrolizumab in Prostate Cancer With Microsatellite Instability–High, Deficient Mismatch Repair, Tumor Mutational Burden–High, and Programmed Death–Ligand 1 Positivity
A 72-year-old man initially presented with prostate cancer and a metastatic right rib lesion. He developed rapid progression on androgen deprivation therapy in 7 months and subsequent treatment with enzalutamide in 3 months. Biomarker studies after progression to castration-resistant prostate…
-
Artikel Jurnal
Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis
Abstract Penile squamous cell carcinoma (PSCC) is a rare malignancy, and first-line therapy typically involves cisplatin-based chemotherapy. However, these regimens are often unsuitable for patients with poor performance status or advanced age due to their toxicity. This retrospective, multicenter…
-
Artikel Jurnal
Safety, Efficacy, and Central Nervous System Control in Patients with High Baseline Risk Factors Treated with Tarlatamab for SCLC or Extrapulmonary Small Cell Carcinoma
Introduction: SCLC remains the most aggressive lung cancer with a poor prognosis. Tarlatamab, a bispecific T-cell engager, is approved for use in extensive-stage SCLC after progression on a platinum-based chemotherapy on the basis of the DeLLphi-301 trial. Because of the restrictive inclusion…